Actively Recruiting
Personalized Pharmacotherapy Using Pharmacogenetics in Veterans
Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2025-03-13
155
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is an observational clinical trial aimed at to evaluate the use of pharmacogenetic testing (PGx) for mental health treatment in members and Veterans of the CAF and RCMP patient population as well as the attitudes of both St. Joseph's OSI Clinic Psychiatrists and patients towards PGx. Both OSI Clinic Psychiatrists participants and patient participants will be administered a brief demographic survey in addition to a survey examining their views on, and current knowledge of PGx. Patient participants will have an opportunity to opt-in to or opt-out of receiving PGx. For patient participants who opt-in to PGx (PGx-guided treatment group), a report summarizing the PGx results will be sent to each patient participants' respective OSI Clinic Psychiatrist, alongside a questionnaire that captures the OSI Clinic Psychiatrist participant's treatment planning and changes to treatment planning. Where applicable, past treatment data from patient participants acquired at the St. Joseph's OSI Clinic will be used to identify the number of prior medication changes. Patient participants who opt-out of PGx but continue to receive pharmacologic care at the St. Joseph's OSI Clinic will act as a standard care comparator treatment group. Patient participant's outcomes including PTSD, depression and anxiety severity, and medication-related side effects, will be assessed until the patient participant is discharged from the OSI Clinic or after 24 weeks, whichever comes first. All patient participants, regardless of their study treatment group, will have their symptomatology collected via standard care data collection protocol (Client Reported Outcomes Monitoring Information System (CROMIS) and electronic medical records (EMR)); a self-report assessing the presence of side effects will be completed via Lawson REDCap. OSI Clinic Psychiatrist participants and patient participants will be asked to complete a virtual exit interview at the end of their participation.
CONDITIONS
Official Title
Personalized Pharmacotherapy Using Pharmacogenetics in Veterans
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provider participant must be at least 18 years old
- Provider participant must speak and write English
- Provider participant must currently work as an OSI Clinic Psychiatrist at London St. Joseph's OSI Clinic
- Psychiatrist must have an active caseload of patients being treated for operational stress injuries (OSIs)
- Patient participant must be a Veteran who is a member of the Canadian Armed Forces or RCMP
- Patient participant must be at least 18 years old
- Patient participant must be a current patient at the London St. Joseph's OSI Clinic
- Patient participant must have a current diagnosis of an operational stress injury (OSI)
- Patient participant must speak and write English
- Patient participant must consent to use of CROMIS data for this study
- Patient participant must consent to use of prior OSI Clinic data for research purposes if applicable
You will not qualify if you...
- Any participant (provider or patient) unable to provide informed consent for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MacDonald Franklin OSI Research and Innovation Centre
London, Ontario, Canada, N6C 0A7
Actively Recruiting
Research Team
N
Natalie Ein, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here